| David W. Mims |
David W. Mims is currently the Chief Executive Officer at Progenics Pharmaceuticals, Inc. He is also currently serving as a Director at SouthPoint Bank, Guideway Care, Inc., The American Institute of Certified Public Accountants, and the Alabama Society of Certified Public Accountants. In his former positions, Mr. Mims worked as a Director at The University of Alabama and SouthPoint Bancshares, Inc. He also served as a Senior Accountant at Ernst & Young LLP and held executive roles at Aptalis Pharma Canada ULC, Aptalis Pharma, Inc., Aptalis Pharma US, Inc., and Cebert Pharmaceuticals, Inc.Mr. Mims obtained his undergraduate degree from Auburn University. |
